Clinical implications of inhibition of the late sodium current : ranolazineBASSAND, Jean-Pierre.European heart journal supplements. 2006, Vol 8, Num A, issn 1520-765X, A14-A19Conference Paper

Ranolazine as a Cardioplegia Additive Improves Recovery of Diastolic Function in Isolated Rat HeartsHWANG, Hyosook; ARCIDI, Joseph M; HALE, Sharon L et al.Circulation (New York, N.Y.). 2009, Vol 120, Num 11, issn 0009-7322, S16-S21, SUP1Conference Paper

Ranolazine Improves Cardiac Diastolic Dysfunction Through Modulation of Myofilament Calcium SensitivityLOVELOCK, Joshua D; MONASKY, Michelle M; DEWAN ZENG et al.Circulation research. 2012, Vol 110, Num 6, pp 841-850, issn 0009-7330, 10 p.Article

Ranolazine : A New Option in the Management of Chronic Stable AnginaDOBESH, Paul P; TRUJILLO, Toby C.Pharmacotherapy. 2007, Vol 27, Num 12, pp 1659-1676, issn 0277-0008, 18 p.Article

Gender difference in ranolazine pharmacokinetics in ratsLIU, X. D; XIE, L; LIANG, Y et al.European journal of drug metabolism and pharmacokinetics. 2003, Vol 28, Num 2, pp 119-123, issn 0378-7966, 5 p.Article

Ranolazine for the management of coronary artery diseaseCHENG, Judy W. M.Clinical therapeutics. 2006, Vol 28, Num 12, pp 1996-2007, issn 0149-2918, 12 p.Article

Ranolazine : A new approach to management of patients with anginaTAFRESHI, Mohammad J; FISHER, Edward.The Annals of pharmacotherapy. 2006, Vol 40, Num 4, pp 689-693, issn 1060-0280, 5 p.Article

Clinical pharmacokinetics of ranolazineJERLING, Markus.Clinical pharmacokinetics. 2006, Vol 45, Num 5, pp 469-491, issn 0312-5963, 23 p.Article

Evolving needs: treatment revolutionEuropean heart journal supplements. 2004, Vol 6, Num I, issn 1520-765X, 20 p.Conference Proceedings

Comparative efficacy of ranolazine versus atenolol for chronic angina pectorisROUSSEAU, Michel F; POULEUR, Hubert; COCCO, Giuseppe et al.The American journal of cardiology. 2005, Vol 95, Num 3, pp 311-316, issn 0002-9149, 6 p.Article

Anti-Anginal and Anti-Ischemic Effects of Late Sodium Current Inhibition : The late sodium current in the Heart: Basic and Clinical AspectsWIMMER, Neil J; STONE, Peter H.Cardiovascular drugs and therapy. 2013, Vol 27, Num 1, pp 69-77, issn 0920-3206, 9 p.Article

The mechanism of ranolazine action to reduce ischemia-induced diastolic dysfunctionBELARDINELLI, Luiz; SHRYOCK, John C; FRASER, Heather et al.European heart journal supplements. 2006, Vol 8, Num A, issn 1520-765X, A10-A13Conference Paper

Ranolazine : a novel agent that improves dysfunctional sodium channelsPHAM, D. Q; MEHTA, M.International journal of clinical practice (Esher). 2007, Vol 61, Num 5, pp 864-872, issn 1368-5031, 9 p.Article

Effect of Ranolazine on Left Ventricular Dyssynchrony in Patients With Coronary Artery DiseaseVENKATARAMAN, Rajesh; JI CHEN; GARCIA, Ernest V et al.The American journal of cardiology. 2012, Vol 110, Num 10, pp 1440-1445, issn 0002-9149, 6 p.Article

Inhibition of the late sodium current as a potential cardioprotective principle : effects of the late sodium current inhibitor ranolazineBELARDINELLI, L; SHRYOCK, J. C; FRASER, H et al.Heart. Supplement. 2006, Vol 92, Num 4, iv6-iv14Article

Role of Late Sodium Channel Current Block in the Management of Atrial Fibrillation : The late sodium current in the Heart: Basic and Clinical AspectsBURASHNIKOV, Alexander; ANTZELEVITCH, Charles.Cardiovascular drugs and therapy. 2013, Vol 27, Num 1, pp 79-89, issn 0920-3206, 11 p.Article

Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysisSAVARESE, Gianluigi; ROSANO, Giuseppe; FIMIANI, Luigi et al.International journal of cardiology. 2013, Vol 169, Num 4, pp 262-270, issn 0167-5273, 9 p.Article

Clinical Experience with Ranolazine in a Veteran Population with Chronic Stable AnginaREEDER, Don N; GILLETTE, Michael A; FRANCK, Andrew J et al.The Annals of pharmacotherapy. 2012, Vol 46, Num 1, pp 42-50, issn 1060-0280, 9 p.Article

Effect of ranolazine on arterial endothelial function in patients with type 2 diabetes mellitusLAMENDOLA, Priscilla; NERLA, Roberto; LANZA, Gaetano A et al.Atherosclerosis. 2013, Vol 226, Num 1, pp 157-160, issn 0021-9150, 4 p.Article

Determination of ranolazine in human plasma by LC-MS/MS and its application in bioequivalence studyBHAUMIK, Uttam; GHOSH, Animesh; AMLAN KANTI SARKAR et al.Journal of pharmaceutical and biomedical analysis. 2008, Vol 48, Num 5, pp 1404-1410, issn 0731-7085, 7 p.Article

Sensitive quantification of ranolazine in human plasma by liquid chromatography-tandem mass spectrometry with positive electrospray ionizationLEI TIAN; JUANJUAN JIANG; YILING HUANG et al.Journal of chromatography. B. 2007, Vol 846, Num 1-2, pp 346-350, issn 1570-0232, 5 p.Article

Effects of ranolazine on exercise tolerance and HbA_1c in patients with chronic angina and diabetesTIMMIS, Adam D; CHAITMAN, Bernard R; CRAGER, Michael et al.European heart journal. 2006, Vol 27, Num 1, pp 42-48, issn 0195-668X, 7 p.Article

Chemo-enzymatic synthesis of both enantiomers of the anti-anginal drug ranolazineMOEN, Anders Riise; KARSTAD, Rasmus; ANTHONSEN, Thorleif et al.Biocatalysis and biotransformation (Print). 2005, Vol 23, Num 1, pp 45-51, issn 1024-2422, 7 p.Article

Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrationsYAMADA, Shigeyuki; XIU QUAN ZHANG; KADONO, Toshie et al.Toxicology and applied pharmacology. 2009, Vol 236, Num 1, pp 71-77, issn 0041-008X, 7 p.Article

A pilot study of ranolazine in patients with intermittent claudicationMA, A; GARLAND, W. T; SMITH, W. B et al.International angiology. 2006, Vol 25, Num 4, pp 361-369, issn 0392-9590, 9 p.Article